By Susanna Moon
Chicago, June 26 - UBS AG, London Branch priced $1.16 million of 7.4% airbag autocallable yield optimization notes due June 30, 2014 linked to Biogen Idec Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.
Interest is payable monthly.
The notes will be called at par if Biogen shares close at or above the initial share price on quarterly observation date.
The payout at maturity will be par unless the final share price is less than the conversion price, in which case the payout will be a number of Biogen shares equal to $1,000 divided by the conversion price. The conversion price is 80% of the initial share price.
UBS Financial Services Inc. UBS Investment Bank are the underwriters.
| Issuer: | UBS AG, London Branch
|
| Issue: | Airbag autocallable yield optimization notes
|
| Underlying stock: | Biogen Idec Inc. (Symbol: BIIB)
|
| Amount: | $1,156,000
|
| Maturity: | June 30, 2014
|
| Coupon: | 7.4%, payable monthly
|
| Price: | Par
|
| Payout at maturity: | If final share price is less than conversion price, 6.2826 Biogen shares; otherwise, par
|
| Call: | At par if Biogen shares close at or above initial share price on quarterly observation date
|
| Initial share price: | $198.96
|
| Conversion price: | $159.17, 80% of initial share price
|
| Pricing date: | June 21
|
| Settlement date: | June 28
|
| Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
| Fees: | 1.5%
|
| Cusip: | 90271L122
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
